These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2898011)

  • 1. Topographical distribution of neurochemical changes in Alzheimer's disease.
    Procter AW; Lowe SL; Palmer AM; Francis PT; Esiri MM; Stratmann GC; Najlerahim A; Patel AJ; Hunt A; Bowen DM
    J Neurol Sci; 1988 Apr; 84(2-3):125-40. PubMed ID: 2898011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism.
    Tamminga CA; Foster NL; Fedio P; Bird ED; Chase TN
    Neurology; 1987 Jan; 37(1):161-5. PubMed ID: 2879258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease.
    Selden N; Geula C; Hersh L; Mesulam MM
    Neuroscience; 1994 Jun; 60(3):621-36. PubMed ID: 7523983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of glutaminase-positive cortical neurons in Alzheimer's disease.
    Akiyama H; McGeer PL; Itagaki S; McGeer EG; Kaneko T
    Neurochem Res; 1989 Apr; 14(4):353-8. PubMed ID: 2761669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P; Katzman R; Terry RD
    Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.
    Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM
    Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.
    Bowen DM; Najlerahim A; Procter AW; Francis PT; Murphy E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9504-8. PubMed ID: 2574463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.
    Foster NL; Tamminga CA; O'Donohue TL; Tanimoto K; Bird ED; Chase TN
    Neurosci Lett; 1986 Jan; 63(1):71-5. PubMed ID: 3754039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms.
    Procter AW; Francis PT; Stratmann GC; Bowen DM
    Neurochem Res; 1992 Sep; 17(9):917-22. PubMed ID: 1357564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease.
    Palmer AM; Procter AW; Stratmann GC; Bowen DM
    Neurosci Lett; 1986 May; 66(2):199-204. PubMed ID: 3014387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism.
    Najlerahim A; Bowen DM
    Biochem J; 1988 Apr; 251(1):305-8. PubMed ID: 3390157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical characteristics of early and late onset types of Alzheimer's disease.
    Rossor MN; Iversen LL; Reynolds GP; Mountjoy CQ; Roth M
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):961-4. PubMed ID: 6142750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients.
    Morrison JH; Rogers J; Scherr S; Benoit R; Bloom FE
    Nature; 1985 Mar 7-13; 314(6006):90-2. PubMed ID: 2858056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.
    Procter AW; Palmer AM; Francis PT; Lowe SL; Neary D; Murphy E; Doshi R; Bowen DM
    J Neurochem; 1988 Mar; 50(3):790-802. PubMed ID: 3339353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline acetyltransferase and somatostatin levels in aged Microcebus murinus brain.
    Dournaud P; Gautron JP; Pattou E; Bons N; Mestre N; Petter A; Kordon C; Epelbaum J
    Neurobiol Aging; 1994; 15(6):727-31. PubMed ID: 7891828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of neuronal tangles in somatostatin neurones in Alzheimer's disease.
    Roberts GW; Crow TJ; Polak JM
    Nature; 1985 Mar 7-13; 314(6006):92-4. PubMed ID: 2858057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
    Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
    J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.